The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS)

被引:164
作者
Beebe, AM
Cua, DJ
Malefyt, RD
机构
[1] DNAX Res Inst Mol & Cellular Biol Inc, Dept Immunol, Palo Alto, CA 94304 USA
[2] DNAX Res Inst Mol & Cellular Biol Inc, Dept Expt Pathol, Palo Alto, CA 94304 USA
关键词
IL-10; inflammation; regulatory T cells; SLE; EAE;
D O I
10.1016/S1359-6101(02)00025-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interleukin-10 (IL-10) is an immunoregulatory cytokine that plays a crucial role in inflammatory and immune reactions. It has potent anti-inflammatory and immunosuppressive activities on myeloid cell functions which forms a solid basis for its use in acute and chronic inflammatory diseases. Here, we discuss the role of IL-10 in autoimmune diseases and examine its beneficial effects in cellular-based autoimmune diseases such as multiple sclerosis (MS) or its involvement in humoral-based autoimmune diseases such as systemic lupus erythematosus (SLE). Inhibition of the immune stimulatory activities of IL-10 may provide novel approaches in the treatment of Immoral autoimmune diseases, infectious diseases and cancer. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:403 / 412
页数:10
相关论文
共 173 条
  • [1] Alarcón-Riquelme ME, 1999, J RHEUMATOL, V26, P2148
  • [2] Interleukin-10 (IL-10) secretion in systemic lupus erythematosus and rheumatoid arthritis: IL-10-dependent CD4+CD45RO+ T cell B cell antibody synthesis
    AlJanadi, M
    AlDalaan, A
    AlBalla, S
    AlHumaidi, M
    Raziuddin, S
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 1996, 16 (04) : 198 - 207
  • [3] ALJANADI M, 1993, J RHEUMATOL, V20, P1885
  • [4] Allavena P, 1998, EUR J IMMUNOL, V28, P359, DOI 10.1002/(SICI)1521-4141(199801)28:01<359::AID-IMMU359>3.0.CO
  • [5] 2-4
  • [6] Effect of intravenous cyclophosphamide in systemic lupus erythematosus: relation to lymphocyte subsets and activation markers
    Amano, H
    Morimoto, S
    Kaneko, H
    Tokano, Y
    Takasaki, Y
    Hashimoto, H
    [J]. LUPUS, 2000, 9 (01) : 26 - 32
  • [7] Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8- and CD8+ T cells in systemic lupus erythematosus
    Amel-Kashipaz, MR
    Huggins, ML
    Lanyon, P
    Robins, A
    Todd, I
    Powell, RJ
    [J]. JOURNAL OF AUTOIMMUNITY, 2001, 17 (02) : 155 - 163
  • [8] Inactive systemic lupus erythematosus is associated with a normal stimulated Th1/Th2 cytokine secretory pattern
    Amit, M
    Mor, A
    Weissgarten, J
    Rosenberg, R
    Ramot, Y
    Wysenbeek, AJ
    Rapoport, MJ
    [J]. CYTOKINE, 2000, 12 (09) : 1405 - 1408
  • [9] Production of IL-1β, IL-1 receptor antagonist and IL-10 by mononuclear cells from patients with SLE
    Andersen, LS
    Petersen, J
    Svenson, M
    Bendtzen, K
    [J]. AUTOIMMUNITY, 1999, 30 (04) : 235 - 242
  • [10] ARAI T, 1995, J IMMUNOL, V155, P5743